These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 19047114)

  • 1. Analysis of gene expression in early-stage ovarian cancer.
    Marchini S; Mariani P; Chiorino G; Marrazzo E; Bonomi R; Fruscio R; Clivio L; Garbi A; Torri V; Cinquini M; Dell'Anna T; Apolone G; Broggini M; D'Incalci M
    Clin Cancer Res; 2008 Dec; 14(23):7850-60. PubMed ID: 19047114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patterns of gene expression in different histotypes of epithelial ovarian cancer correlate with those in normal fallopian tube, endometrium, and colon.
    Marquez RT; Baggerly KA; Patterson AP; Liu J; Broaddus R; Frumovitz M; Atkinson EN; Smith DI; Hartmann L; Fishman D; Berchuck A; Whitaker R; Gershenson DM; Mills GB; Bast RC; Lu KH
    Clin Cancer Res; 2005 Sep; 11(17):6116-26. PubMed ID: 16144910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome.
    Tothill RW; Tinker AV; George J; Brown R; Fox SB; Lade S; Johnson DS; Trivett MK; Etemadmoghadam D; Locandro B; Traficante N; Fereday S; Hung JA; Chiew YE; Haviv I; ; Gertig D; DeFazio A; Bowtell DD
    Clin Cancer Res; 2008 Aug; 14(16):5198-208. PubMed ID: 18698038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selection of potential markers for epithelial ovarian cancer with gene expression arrays and recursive descent partition analysis.
    Lu KH; Patterson AP; Wang L; Marquez RT; Atkinson EN; Baggerly KA; Ramoth LR; Rosen DG; Liu J; Hellstrom I; Smith D; Hartmann L; Fishman D; Berchuck A; Schmandt R; Whitaker R; Gershenson DM; Mills GB; Bast RC
    Clin Cancer Res; 2004 May; 10(10):3291-300. PubMed ID: 15161682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular and prognostic distinction between serous ovarian carcinomas of varying grade and malignant potential.
    Meinhold-Heerlein I; Bauerschlag D; Hilpert F; Dimitrov P; Sapinoso LM; Orlowska-Volk M; Bauknecht T; Park TW; Jonat W; Jacobsen A; Sehouli J; Luttges J; Krajewski M; Krajewski S; Reed JC; Arnold N; Hampton GM
    Oncogene; 2005 Feb; 24(6):1053-65. PubMed ID: 15558012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene expression in ovarian cancer reflects both morphology and biological behavior, distinguishing clear cell from other poor-prognosis ovarian carcinomas.
    Schwartz DR; Kardia SL; Shedden KA; Kuick R; Michailidis G; Taylor JM; Misek DE; Wu R; Zhai Y; Darrah DM; Reed H; Ellenson LH; Giordano TJ; Fearon ER; Hanash SM; Cho KR
    Cancer Res; 2002 Aug; 62(16):4722-9. PubMed ID: 12183431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene expression profiling of epithelial ovarian tumours correlated with malignant potential.
    Warrenfeltz S; Pavlik S; Datta S; Kraemer ET; Benigno B; McDonald JF
    Mol Cancer; 2004 Oct; 3():27. PubMed ID: 15471544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic analysis of early- versus late-stage ovarian tumors.
    Shridhar V; Lee J; Pandita A; Iturria S; Avula R; Staub J; Morrissey M; Calhoun E; Sen A; Kalli K; Keeney G; Roche P; Cliby W; Lu K; Schmandt R; Mills GB; Bast RC; James CD; Couch FJ; Hartmann LC; Lillie J; Smith DI
    Cancer Res; 2001 Aug; 61(15):5895-904. PubMed ID: 11479231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BTF4/BTNA3.2 and GCS as candidate mRNA prognostic markers in epithelial ovarian cancer.
    Le Page C; Ouellet V; Quinn MC; Tonin PN; Provencher DM; Mes-Masson AM
    Cancer Epidemiol Biomarkers Prev; 2008 Apr; 17(4):913-20. PubMed ID: 18398031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patterns of gene expression that characterize long-term survival in advanced stage serous ovarian cancers.
    Berchuck A; Iversen ES; Lancaster JM; Pittman J; Luo J; Lee P; Murphy S; Dressman HK; Febbo PG; West M; Nevins JR; Marks JR
    Clin Cancer Res; 2005 May; 11(10):3686-96. PubMed ID: 15897565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microarray expression identification of differentially expressed genes in serous epithelial ovarian cancer compared with bulk normal ovarian tissue and ovarian surface scrapings.
    Grisaru D; Hauspy J; Prasad M; Albert M; Murphy KJ; Covens A; Macgregor PF; Rosen B
    Oncol Rep; 2007 Dec; 18(6):1347-56. PubMed ID: 17982616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evaluation of Ron and Met proto-oncogene expression in epithelial ovarian tumors].
    Fracchioli S; Katsaros D; Maggiora P; Di Renzo MF; Massobrio M
    Minerva Ginecol; 1999 Oct; 51(10):359-64. PubMed ID: 10638160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IGF axis gene expression patterns are prognostic of survival in epithelial ovarian cancer.
    Spentzos D; Cannistra SA; Grall F; Levine DA; Pillay K; Libermann TA; Mantzoros CS
    Endocr Relat Cancer; 2007 Sep; 14(3):781-90. PubMed ID: 17914107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HOXA7 in epithelial ovarian cancer: interrelationships between differentiation and clinical features.
    Ota T; Gilks CB; Longacre T; Leung PC; Auersperg N
    Reprod Sci; 2007 Sep; 14(6):605-14. PubMed ID: 17959889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening for genes associated with ovarian cancer prognosis.
    Chang XH; Zhang L; Yang R; Feng J; Cheng YX; Cheng HY; Ye X; Fu TY; Cui H
    Chin Med J (Engl); 2009 May; 122(10):1167-72. PubMed ID: 19493465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathological significance of circadian rhythm-related gene expression levels in patients with epithelial ovarian cancer.
    Tokunaga H; Takebayashi Y; Utsunomiya H; Akahira J; Higashimoto M; Mashiko M; Ito K; Niikura H; Takenoshita S; Yaegashi N
    Acta Obstet Gynecol Scand; 2008; 87(10):1060-70. PubMed ID: 18720043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive analysis of 20q13 genes in ovarian cancer identifies ADRM1 as amplification target.
    Fejzo MS; Dering J; Ginther C; Anderson L; Ramos L; Walsh C; Karlan B; Slamon DJ
    Genes Chromosomes Cancer; 2008 Oct; 47(10):873-83. PubMed ID: 18615678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of gene expression profiles to stage concurrent endometrioid tumors of the endometrium and ovary.
    Guirguis A; Elishaev E; Oh SH; Tseng GC; Zorn K; DeLoia JA
    Gynecol Oncol; 2008 Feb; 108(2):370-6. PubMed ID: 18083218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting clinical outcome through molecular profiling in stage III melanoma.
    John T; Black MA; Toro TT; Leader D; Gedye CA; Davis ID; Guilford PJ; Cebon JS
    Clin Cancer Res; 2008 Aug; 14(16):5173-80. PubMed ID: 18698035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of gene expression profiles in normal and neoplastic ovarian tissue samples identifies candidate molecular markers of epithelial ovarian cancer.
    Welsh JB; Zarrinkar PP; Sapinoso LM; Kern SG; Behling CA; Monk BJ; Lockhart DJ; Burger RA; Hampton GM
    Proc Natl Acad Sci U S A; 2001 Jan; 98(3):1176-81. PubMed ID: 11158614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.